| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $84.4M | — | +17.6% |
| Cost of Revenue | $51.5M | — | +15.2% |
| Gross Profit | $32.9M | — | +21.6% |
| R&D Expense | $5.6M | — | +14.9% |
| SG&A Expense | $32.1M | — | +20.1% |
| Operating Income | $340K | — | +666.7% |
| Pre-tax Income | -$158K | — | +87.7% |
| Income Tax | $129K | — | +138.9% |
| Net Income | -$319K | — | +66.1% |
| EPS (Basic) | -$0.02 | — | +71.4% |
| EPS (Diluted) | -$0.02 | — | +71.4% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $82.5M | -5.6% | — |
| Accounts Receivable | $61.4M | +9.0% | +22.2% |
| Inventory | $82.9M | +0.1% | -1.2% |
| Current Assets | $246.1M | -0.4% | +1.9% |
| Total Assets | $453.8M | -0.4% | -0.0% |
| Current Liabilities | $55.0M | -0.5% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$596K | — | -111.4% |
| Investing Cash Flow | -$3.1M | — | -103.1% |
| Financing Cash Flow | -$502K | — | -360.6% |
| +2.8% |
| Long-term Debt | $20.6M | +0.1% | -34.5% |
| Total Liabilities | $119.4M | -0.2% | -7.3% |
| Stockholders' Equity | $334.7M | -0.5% | +3.0% |